Company

 

Company

 

: Steminent Biotherapeutics Inc. (Steminent) is a leading, clinical stage, Taiwan-based cell therapy company which has built a proprietary allogeneic Stemchymal® platform with which to develop a pipeline of pre-clinical and clinical stage therapeutic programs for the treatment of a range of diseases.
Website : www.steminent.com
Headquarter : Taipei, Taiwan (R.O.C)
Year founded : 2009
Offices : Taipei Office, Shanghai Office, San Diego Office
Size : 51-200 employees
Specialities : Cell Therapy, Degenerative Diseases, Acute Syndromes Diseases, Matabolic Disorders Diseases